Michael Mahoney Boston Scientific CEO Rating

Boston Scientific CEO Michael Mahoney Bio

Mr. Michael F. Mahoney, also known as Mike, has been the Chief Executive Officer of Boston Scientific Corporation since November 1, 2012 and has been its President since October 17, 2011. At Boston Scientific Corporation, Mr. Mahoney is responsible for Boston Scientific's Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. He joined Boston Scientific in October 2011, having established a track record of more than 22 years of healthcare experience in building market leading global businesses in medical devices, capital equipment and healthcare IT service businesses at best-in-class companies. Prior to joining Boston Scientific, he served as Worldwide Chairman of Medical Device and Diagnostics Group (MD&D) at Johnson & Johnson from January 3, 2011 to September 2011. He served as a Group Chairman, DePuy Franchise of Johnson & Johnson from April 2007 to January 3, 2011. In this role, he successfully drove a growth strategy via product innovation, multiple acquisitions and International expansion, particularly in China and India. Prior to joining Johnson & Johnson, Mr. Mahoney served as the President and Chief Executive Officer of Global Healthcare Exchange (GHX) from January 2001 to March 2007. He built Global Healthcare Exchange through organic development and strategic acquisitions, successfully integrating seven acquisitions and expanding the business into Europe and Canada. He built his early career at General Electric Medical Systems, where he spent 12 years, in a variety of advancing leadership roles for domestic and global businesses in CT, MRI, X-ray, Healthcare IT and Nuclear Medicine, culminating in the role of General Manager of the Healthcare Information Technology business. He has been Chairman of Boston Scientific Corporation since May 3, 2016. He has been a Director of Boston Scientific Corporation since November 1, 2012. He serves as a Director of BridgePoint Medical, Inc. He has been Independent Director of Baxter International Inc. since October 21, 2015. Mr. Mahoney holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University.

Boston Scientific CEO Michael Mahoney At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Boston Scientific.

Based on 363 ratings, Michael Mahoney ranks right below Biosense Webster's CEO, David Shepherd.

Boston Scientific's CEO is highly regarded by the IT department and the Marketing department. However, employees who have been at the company Over 10 Years, the Sales department, and the Product department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.